Quan Zhou
Direttore/Membro del Consiglio presso Beijing Biostar Pharmaceuticals Co. Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 anni |
| Kai Lin Liu | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 4 anni |
| Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 anni |
| Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 anni |
| Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 anni |
| Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 anni |
| Shu Feng Zhang | M | 55 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 8 anni |
| De Qing Tan | M | 57 |
Southwest Jiaotong University
| 22 anni |
| Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 anni |
| Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 anni |
| Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 anni |
| Zuo Ping Xiao | M | 49 |
Southwest Jiaotong University
| 17 anni |
| Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 anni |
| Hui Wu Wang | M | 52 |
Southwest Jiaotong University
| 15 anni |
| Guang Wu | M | 66 |
Southwest Jiaotong University
| 16 anni |
| Fei Peng | M | 50 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Hong Yu Zhuo | M | 45 |
Southwest Jiaotong University
| 7 anni |
| Lei Lei | M | 40 |
Southwest Jiaotong University
| 6 anni |
| Shun Shen | M | 51 |
Southwest Jiaotong University
| 7 anni |
| Yan Fang Xu | M | 56 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Ying Wang | M | 56 |
Southwest Jiaotong University
| 3 anni |
| Xing Zhang | M | 33 |
Southwest Jiaotong University
| 4 anni |
| Xu Dong Chen | M | 57 |
Southwest Jiaotong University
| 3 anni |
| Peng Wang | M | 43 |
Southwest Jiaotong University
| 3 anni |
| Yu Peng Li | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 anni |
| Xian Jun Wang | M | 53 |
Southwest Jiaotong University
| 1 anni |
| Yao Chao Chen | M | 39 |
Southwest Jiaotong University
| 4 anni |
| Wu Li Gao | F | 40 |
Southwest Jiaotong University
| 4 anni |
| Hua Wang | M | 37 |
Southwest Jiaotong University
| 4 anni |
| Jing Xiang | M | 48 |
Southwest Jiaotong University
| 3 anni |
| Yu Mao | M | 37 |
Southwest Jiaotong University
| 4 anni |
| Hang Wei | M | 47 |
Southwest Jiaotong University
| 3 anni |
| Xiao Li Shi | F | 38 |
Southwest Jiaotong University
| 4 anni |
| Xiao Long Wu | M | 50 |
Southwest Jiaotong University
| 2 anni |
| Sheng Xiang Lei | M | 59 |
Southwest Jiaotong University
| 3 anni |
| Erke Huang | M | 36 |
Southwest Jiaotong University
| 4 anni |
| Chun Hui Zhang | F | 37 |
Southwest Jiaotong University
| 3 anni |
| Gang Wu | M | 46 |
Southwest Jiaotong University
| 4 anni |
| Xin Pan | M | 36 |
Southwest Jiaotong University
| 4 anni |
| Yong Ye | M | 49 |
Southwest Jiaotong University
| 3 anni |
| Min Xiang | F | 52 |
Southwest Jiaotong University
| 4 anni |
| Li Li Ding | F | 38 |
Southwest Jiaotong University
| 4 anni |
| Jing Yu Jin | M | 58 |
Southwest Jiaotong University
| 3 anni |
| Cha Hua Lin | F | 46 |
Southwest Jiaotong University
| 4 anni |
| Yu Jiang Lu | M | 52 |
Southwest Jiaotong University
| 2 anni |
| He Jiang | M | 58 |
Southwest Jiaotong University
| 1 anni |
| Zhen Ling Wang | M | 43 |
Southwest Jiaotong University
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Cina | 48 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Quan Zhou
- Contatti personali
